Clinical Trial Update: Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer [NA]

View source ↗

Summary

The Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) trial for unresectable cholangiocarcinoma and pancreatic cancer was terminated, with results posted on 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Endoscopic Bipolar Radiofrequency Probe (ENDOHPB)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Cholangiocarcinoma, Pancreatic Cancer | NA | Status: TERMINATED | Results posted: 2017-05-23